The magnitude of difference between IL-1β levels observed in COVID-19 (about 1.0 pg./mL see Step 2d) or sepsis (approximately 20 pg./mL (Gharamti et al., 2021)) compared to IL-1 amounts capable of causing severe disease in humans appears to span orders of magnitude. This evidence concerns the gene IL1B and COVID-19.